- Home
- LNT vs ICLR Comparison
LNT vs ICLR Comparison
Compare LNT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNT | ICLR |
|---|---|---|
| Founded | 1917 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 14.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | LNT | ICLR |
|---|---|---|
| Price | $65.30 | $183.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $69.14 | ★ $202.38 |
| AVG Volume (30 Days) | ★ 1.8M | 954.8K |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 23.58 | N/A |
| EPS | 3.18 | ★ 7.47 |
| Revenue | $4,274,000,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $7.01 | N/A |
| Revenue Next Year | $4.72 | $0.76 |
| P/E Ratio | ★ $20.58 | $24.58 |
| Revenue Growth | ★ 7.77 | N/A |
| 52 Week Low | $56.30 | $125.10 |
| 52 Week High | $69.75 | $228.29 |
Technical Indicators
Market Signals| Indicator | LNT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 55.43 |
| Support Level | $64.30 | $172.55 |
| Resistance Level | $66.04 | $185.31 |
| Average True Range (ATR) | 0.75 | 5.97 |
| MACD | 0.02 | -0.56 |
| Stochastic Oscillator | 66.18 | 57.67 |
Price Performance
Historical ComparisonAbout LNT Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light. Together, IPL and WPL serve nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.